Compare Synopsys, Inc. (SNPS) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Synopsys, Inc. vs Vital Farms Inc — how do they compare? Synopsys, Inc. trades at $376.48 (market cap $72.47B), while Vital Farms Inc trades at $13.78 (market cap $590.45M). The key difference: Synopsys, Inc. is far larger — about 122.7× Vital Farms Inc's market cap, and Vital Farms Inc is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals.
| SNPS | VITL | |
|---|---|---|
Market Cap | $72.47B | $590.45M |
Sector | Technology | Consumer Staples |
52-Week High | $645.59 | $52.41 |
52-Week Low | $378.46 | $8.28 |
Enterprise Value | $80.82B | $593.26M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Synopsys (SNPS) trades at $378.47, down 1.51% amid a semiconductor sector downturn. The stock shows bearish technical signals but maintains strong fundamentals with consistent earnings beats and a high analyst buy consensus of 82.76%. Recent news highlights the company's strategic pivot to AI design tools and margin expansion following the Ansys integration.
Outlook remains positive long-term due to SNPS's critical role in AI chip design, though near-term risks include sector volatility and execution of high-margin transitions. The consensus price target of $559.50 implies significant upside, but investors should monitor competitive pressures and macroeconomic headwinds.
Vital Farms (VITL) trades at $13.76, up 1.55% with a bullish technical signal from moving averages. The company shows solid profitability with 6.1% net margin and 15.44% ROE, though recent earnings missed expectations in two of the last three quarters. Analyst consensus is positive with 56% buy ratings and a $13.50 price target, while news highlights declining short interest and ongoing class action lawsuits.
The stock presents a mixed outlook with strong fundamentals offset by legal risks and earnings volatility. Valuation appears reasonable with P/E of 13.02 and P/S of 0.79, but investors should weigh the class action litigation's potential impact against the company's operational strength in the natural foods sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
